Kosasa T S, Nakayama R T, Hale R W, Rinzler G S, Freitas C A
Acta Obstet Gynecol Scand. 1985;64(5):421-6. doi: 10.3109/00016348509155160.
A prospective study comparing intravenous ritodrine and terbutaline was initiated to assess the efficacy of each drug in arresting preterm labor. Delivery was delayed for 25.8 days in patients treated with terbutaline and 13.0 days in patients treated with ritodrine. Patients treated with terbutaline gave birth to infants with a mean birthweight of 2 588 grams and 60% achieved a gestation of 36 weeks. Patients treated with ritodrine gave birth to infants with a mean birthweight of 2 392 grams and 39% achieved a gestation of 36 weeks. From this study it is evident that parturition was more effectively delayed in women treated with terbutaline than in a similar group of women treated with ritodrine.
开展了一项前瞻性研究,比较静脉注射利托君和特布他林,以评估每种药物在抑制早产方面的疗效。接受特布他林治疗的患者分娩延迟了25.8天,接受利托君治疗的患者分娩延迟了13.0天。接受特布他林治疗的患者所生婴儿的平均出生体重为2588克,60%的患者妊娠达到36周。接受利托君治疗的患者所生婴儿的平均出生体重为2392克,39%的患者妊娠达到36周。从这项研究可以明显看出,与接受利托君治疗的类似女性群体相比,接受特布他林治疗的女性分娩延迟更有效。